F-18 Altanserin PET Study of Patients Receiving Clozapine

NCT01398189 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2013-11-21

No results posted yet for this study

Summary

To examine the feasibility of molecular imaging markers in clinical psychopharmacology

Conditions

Interventions

DRUG

clozapine

C-11 clozapine

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Jae Seung Chang, MD, PhD · Seoul National University Bundang Hospital

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01398189 on ClinicalTrials.gov